- Home
- ZIP vs REPL Comparison
ZIP vs REPL Comparison
Compare ZIP & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIP
- REPL
- Stock Information
- Founded
- ZIP 2010
- REPL 2015
- Country
- ZIP United States
- REPL United States
- Employees
- ZIP N/A
- REPL N/A
- Industry
- ZIP Diversified Commercial Services
- REPL Biotechnology: Pharmaceutical Preparations
- Sector
- ZIP Consumer Discretionary
- REPL Health Care
- Exchange
- ZIP Nasdaq
- REPL Nasdaq
- Market Cap
- ZIP 972.5M
- REPL 780.3M
- IPO Year
- ZIP 2021
- REPL 2018
- Fundamental
- Price
- ZIP $6.90
- REPL $10.14
- Analyst Decision
- ZIP Hold
- REPL Strong Buy
- Analyst Count
- ZIP 6
- REPL 6
- Target Price
- ZIP $9.80
- REPL $17.50
- AVG Volume (30 Days)
- ZIP 381.7K
- REPL 794.9K
- Earning Date
- ZIP 02-20-2025
- REPL 02-06-2025
- Dividend Yield
- ZIP N/A
- REPL N/A
- EPS Growth
- ZIP N/A
- REPL N/A
- EPS
- ZIP 0.03
- REPL N/A
- Revenue
- ZIP $498,903,000.00
- REPL N/A
- Revenue This Year
- ZIP N/A
- REPL N/A
- Revenue Next Year
- ZIP N/A
- REPL $300.41
- P/E Ratio
- ZIP $234.53
- REPL N/A
- Revenue Growth
- ZIP N/A
- REPL N/A
- 52 Week Low
- ZIP $6.51
- REPL $4.92
- 52 Week High
- ZIP $15.35
- REPL $17.00
- Technical
- Relative Strength Index (RSI)
- ZIP 38.64
- REPL 32.06
- Support Level
- ZIP $6.51
- REPL $10.00
- Resistance Level
- ZIP $7.07
- REPL $11.20
- Average True Range (ATR)
- ZIP 0.32
- REPL 0.84
- MACD
- ZIP 0.05
- REPL -0.20
- Stochastic Oscillator
- ZIP 37.86
- REPL 3.93
About ZIP ZipRecruiter Inc.
ZipRecruiter Inc is an online employment marketplace. It was founded to make meaningful connections between job seekers and employers. It connects millions of job seekers with companies of all sizes. It is a two-sided marketplace for work that simplifies the job market for both job seekers and employers. Unlike traditional online job sites, ZipRecruiter works like a matchmaker curating job opportunities for job seekers, and candidates for employers.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.